Effect of lead on IL-8 production and cell proliferation in human oral keratinocytes

Asian Pacific Journal of Tropical Medicine

Volumn 3, Issue 6, 2010, Pages 475-478

  Srosiri, Thaweboon ^a   Sopee, Poomsawat ^a   Boonyanit, Thaweboon ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cell proliferation; Interleukin 8; Lead; Oral keratinocytes; Ulcerative stomatitis

Indexed keywords

GLUTAMIC ACID; INTERLEUKIN 8; LEAD;

ARTICLE; CELL COUNT; CELL PROLIFERATION; CHEEK MUCOSA; COLORIMETRY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; KERATINOCYTE; SUPERNATANT;

EID: 77953981507     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(10)60114-9     Document Type: Article

References (26)

1. Landrigan PJ, Todd AC Lead poisoning. West J Med 1994, 161:153-159.
2. Gidlow DA Lead toxicity. Occup Med (Lond) 2004, 54:76-81.
3. ATSDR Toxicological profile for lead 1993, U.S. Public Health Service, Atlanta.
4. Lin-Fu JS Vulnerability of children to lead exposure and toxicity (first of two parts). N Engl J Med 1973, 289:1229-1233.
5. Sen D, Wolfson H, Dilworth M Lead exposure in scaffolders during refurbishment construction activity-an observational study. Occup Med (Lond) 2002, 52:49-54.
6. Pearce JM Burton's line in lead poisoning. Eur Neurol 2007, 57:118-119.
7. Ibels LS, Pollock CA Lead intoxication. Med Toxicol 1986, 1:387-410.
8. Sun A, Chang YF, Chia JS, Chiang CP Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of recurrent aphthous ulcerations. J Oral Pathol Med 2004, 33:133-139.
9. Freshney R Disaggregation of the tissue and primary culture. Culture of animal cells: a manual of basic technique 1994, 124-147. Wiley-Liss, New York. R. Freshney (Ed.).
10. Katsantonis J, Adler Y, Orfanos CE, Zouboulis CC Adamantiades-Behcet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 2000, 201:37-39.
11. Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, et al. Adamantiades-Behcet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 2000, 292:279-284.
12. Toscano CD, Guilarte TR Lead neurotoxicity: from exposure to molecular effects. Brain Res Rev 2005, 49:29-54.
13. al-Dalaan A, al-Sedairy S, al-Balaa S, al-Janadi M, Elramahi K, Bahabri S, et al. Enhanced interleukin 8 secretion in circulation of patients with Behcet's disease. J Rheumatol 1995, 22:904-907.
14. Wang LM, Kitteringham N, Mineshita S, Wang JZ, Nomura Y, Koike Y, et al. The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behcet's disease. Arch Dermatol Res 1997, 289:444-447.
15. Ozoran K, Aydintug O, Tokgoz G, Duzgun N, Tutkak H, Gurler A Serum levels of interleukin-8 in patients with Behcet's disease. Ann Rheum Dis 1995, 54:610.
16. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002, 72:847-855.
17. Peichl P, Ceska M, Broell H, Effenberger F, Lindley IJ Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis. Ann Rheum Dis 1992, 51:19-22.
18. Thaweboon S, Chunhabundit P, Surarit R, Swasdison S, Suppukpatana P Effects of lead on the proliferation, protein production, and osteocalcin secretion of human dental pulp cells in vitro. Southeast Asian J Trop Med Public Health 2002, 33:654-661.
19. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M Growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16:585-601.
20. Kamer AR, Krebs L, Hoghooghi SA, Liebow C Proliferative and apoptotic responses in cancers with special reference to oral cancer. Crit Rev Oral Biol Med 1999, 10:8-78.
21. Greim H, Reuter U Classification of carcinogenic chemicals in the work area by the German MAK Commission: current examples for the new categories. Toxicology 2001, 166:11-23.
22. IARC Inorganic and organic lead compounds. IARC Monogr Eval Carcinog Risks Hum 2006, 87:1-471.
23. Ariza ME, Williams MV Lead and mercury mutagenesis: type of mutation dependent upon metal concentration. J Biochem Mol Toxicol 1999, 13:107-112.
24. Smirnov I, Shafer RH Lead is unusually effective in sequence-specific folding of DNA. J Mol Biol 2000, 296:1-5.
25. Wedrychowski A, Schmidt WN, Hnilica LS The in vivo cross-linking of proteins and DNA by heavy metals. J Biol Chem 1986, 261:3370-3376.
26. Silbergeld EK Facilitative mechanisms of lead as a carcinogen. Mutat Res 2003, 533:121-133.